Number of meta-analyses: 1
Number of clinical trials: 1
Project Description:
Zsolt is focusing on Alzheimer's disease while he is a resident doctor at the Department of Psychiatry and Psychotherapy, Semmelweis University. His first project is a meta-analysis investigating if the elevated amyloid level in the cerebrospinal fluid (CFS) or on computed tomography scan is a prognostic factor of cognitive decline in cognitively unimpaired patients, with or without the presence of hyperphosphorylated Tau protein. He also plans to set up a registry analysis to identify region-specific risk factors for the development of dementia in Hungarian patients. He also aims to clarify the role of cardiovascular disease, diabetes, and late-onset depression by follow-up visits at their „memory ambulance”.
Publications
- Risk of conversion to mild cognitive impairment or dementia among subjects with amyloid and tau pathology: a systematic review and meta-analysis - IF: 9.000, Quality: D1, Journal: Alzheimers Res Ther
- Association of modifiable risk factors with progression to dementia in relation to amyloid and tau pathology - IF: 7.900, Quality: D1, Journal: Alzheimers Res Ther